At The New York Times Prescriptions blog, Duff Wilson says that outside business deals are keeping the pipelines of the major drug companies healthy, instead of internal research projects. According to a recent analysis from Fitch Ratings, the major drug makers are on pace to meet last year's level of 21 new drugs approved in the United States and Europe, but only thanks to acquisition and licensing deals.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.